Image

Effects of Low-level Laser Therapy on Spasticity and Gait Parameters in Chronic Stroke Patients With Spastic Plantar Flexors

Effects of Low-level Laser Therapy on Spasticity and Gait Parameters in Chronic Stroke Patients With Spastic Plantar Flexors

Recruiting
45-70 years
All
Phase N/A

Powered by AI

Overview

Stroke is one of the leading causes of long-term disability worldwide. Many patients who survive a stroke experience muscle stiffness (called spasticity), especially in the ankle and foot muscles, which makes walking difficult and painful. Spasticity in the plantar flexor muscles those that help push the foot down can lead to poor balance, limited mobility, and increased risk of falls.

This study aims to explore the effects of low-level laser therapy (LLLT) on spasticity and walking ability in patients who have had a stroke for more than six months (chronic stroke). LLLT is a non-invasive, painless treatment that uses low-intensity light to stimulate tissue healing, reduce muscle tightness, and improve nerve function.

A total of 18 chronic stroke patients with spastic plantar flexors were included in this randomized controlled trial (RCT). Participants were randomly assigned to one of two groups:

Study group: Received low-level laser therapy along with conventional physiotherapy.

Control group: Received conventional physiotherapy alone. Each patient received therapy for three weeks. The study evaluated outcomes using the Modified Ashworth Scale (MAS) for muscle spasticity, the Wisconsin Gait Scale (WGS) for walking quality, and a Goniometer for ankle joint range of motion. Assessments were done before and after treatment.

The results showed that both groups improved significantly, but patients who received laser therapy demonstrated greater reduction in spasticity and better gait performance compared to those who received conventional therapy alone.

This study suggests that low-level laser therapy can be a useful addition to conventional rehabilitation programs for improving walking ability and reducing spasticity in stroke patients.

Description

Background and Rationale:

After a stroke, damage to the brain can cause increased muscle tone (spasticity), reduced mobility, and altered gait patterns. These issues significantly affect independence and quality of life. Traditional physiotherapy techniques, such as stretching and strengthening, are helpful but often insufficient in chronic cases. Recent evidence suggests that low-level laser therapy (LLLT) can promote cellular recovery, improve blood circulation, and reduce muscle stiffness by enhancing nerve conduction and reducing inflammation.

Study Objective:

To determine the effectiveness of low-level laser therapy in improving spasticity and gait parameters in chronic stroke patients with spastic plantar flexors.

Study Design:

This was a randomized controlled trial conducted on 18 participants diagnosed with chronic stroke and presenting with spasticity of the ankle plantar flexors. Participants were divided into:

Study group (n=9): Received low-level laser therapy (parameters: wavelength 830 nm, power output 50 mW, energy density 6 J/cm²) combined with conventional physiotherapy.

Control group (n=9): Received conventional physiotherapy only (stretching, strengthening, and gait training).

Intervention Duration:

Both groups received treatment sessions five times a week for three weeks.

Outcome Measures:

Spasticity: Measured using the Modified Ashworth Scale (MAS) Gait Parameters: Measured using the Wisconsin Gait Scale (WGS) Ankle Range of Motion (ROM): Measured with a Goniometer

Data Analysis:

Within-group changes were assessed using Friedman's test, and between-group comparisons were made using the Mann-Whitney U test. A p-value ≤ 0.05 was considered statistically significant. Statistical analysis was performed using SPSS version 25.

Results Summary:

Both groups showed significant improvements in spasticity, ankle range of motion, and gait scores; however, the study group demonstrated greater gains in all parameters. The combination of LLLT with physiotherapy enhanced motor control, reduced stiffness, and improved walking quality more effectively than physiotherapy alone.

Conclusion

Low-level laser therapy is a safe, effective, and non-invasive intervention that significantly improves spasticity and gait in chronic stroke patients. Incorporating LLLT into rehabilitation programs may help enhance mobility and functional independence.

Eligibility

Inclusion Criteria:

Patients with Age of 45-70 years. Male and female patients with chronic stroke. Patients determined to have persistent stroke for no less than 1 year A maximum of 2 degrees of plantar flexor spasticity on MAS. (35) Cognitive preserved, having score of 24 to 30 on MMSE. (25) Medical referral for physiotherapy.

Exclusion Criteria:

Patients with uncontrolled metabolic illnesses, orthopedic issues, and other neurologic abnormalities should be excluded as potential confounding factors impacting balance performance. Patients with recurrent stroke. Patients who were at that point performing organized proactive tasks, for example, muscle reinforcing works out, Pilates, yoga or focused energy oxygen consuming activities Patients with Hypoesthesia or possibly Hyperesthesia of the side to be analyzed.

The patients with active contamination and presence of rashes at the site of utilization of the laser application. A neoplastic lesion at the site of application.

Study details
    Stroke
    Spasticity
    Plantar Flexors

NCT07273591

Montiha Azeem

1 February 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.